课题基金 / 基金详情

RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM: PROJECT NO 5218 MATMACORP SARS-COV-2 HIGH THROUGHPUT LABORATORY CAPACITY SCALE-UP

RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM: PROJECT NO 5218 MATMACORP SARS-COV-2 HIGH THROUGHPUT LABORATORY CAPACITY SCALE-UP
快速诊断 (RADX) 技术计划:项目号 5218 MATMACORP SARS-COV-2 高通量实验室容量扩大
批准号:
10505977
负责人:
PHIL KOZERA
金额:
$494.7万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-29 至 2021-04-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
MatMaCorp is an animal health diagnostics company that collaborates with agencies including the Department of Homeland Security (DHS) Science and Technology group and USDA's Meat Animal Research Center (USMARC). In February of 2020, we shifted focus to human health in response to the COVID-19 pandemic. We are working to utilize our portable diagnostic platform, the Solas 8 fluorescent detection device and proprietary tests, with features supportive of rapid, mobile human diagnostics. Our device uses molecular probes to detect and identify specific DNA or RNA (target) sequences, in addition to a mutation or variation (SNP) within a sequence.  Additional Features: ·       Touchscreen interface ·       USB Ports ·       Wi-Fi enabled ·       Mobile Application ·       Automated calling of results   Additionally, our assays are lyophilized and do not require pipettes, centrifuges, or refrigeration and have a twelve-month shelf life. The Covid-19 kits are made for lab-use or field-use, providing flexibility and accessibility. Whether at a workplace, in a lab, or in a mobile testing center, results can be generated in real-time without specialized lab equipment, technical skills, or controlled conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金